Strictly Come Dancing's Pete Wicks revealed he "might need an eye patch" as he faces up to a recurring health issue. Speaking on his own Staying Relevant podcast, 36-year-old Pete shared his ...

Pete Wicks has opened up about his childhood health woes, revealing that he "might need an eye patch" due to a recurring condition. The reality TV star shared in an episode of his podcast Staying ...

Michael Nagle / Bloomberg via Getty Images Shares of Eli Lilly (LLY) fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed first-quarter results that ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow before market hours. Here’s what to look for. Eli Lilly met analysts’ revenue expectations last quarter ...

Legendary New York Giants quarterback Eli Manning may become more than just a franchise icon in the near future, as Bloomberg reported this week that he has spoken to potential investors ...

Eli Lilly is scheduled to report its quarterly results on May 1. The company may report its Q1 results in line with peers. Unlock your all-in-one trading dashboard with real-time alerts, rankings ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Orforglipron, an experimental treatment Eli Lilly is developing for diabetes and weight loss, hit high marks in the first of several pivotal trials. The daily tablet produced blood-sugar ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...